Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AIMT

Aimmune

$26.40

1.23 (4.89%)

, REGN

Regeneron

$384.20

12.47 (3.35%)

08:12
10/15/18
10/15
08:12
10/15/18
08:12
Hot Stocks
Aimmune Therapeutics announces initiation of Phase 2 study of AR101 »

Aimmune Therapeutics…

AIMT

Aimmune

$26.40

1.23 (4.89%)

REGN

Regeneron

$384.20

12.47 (3.35%)

SNY

Sanofi

$42.89

-0.83 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

BAC

Bank of America

$28.42

0.07 (0.25%)

, MRK

Merck

$69.77

1.41 (2.06%)

07:35
10/15/18
10/15
07:35
10/15/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$28.42

0.07 (0.25%)

MRK

Merck

$69.77

1.41 (2.06%)

ZION

Zions Bancorp

$48.26

-0.93 (-1.89%)

ETP

Energy Transfer Partners

$21.66

0.3 (1.40%)

CVE

Cenovus Energy

$8.76

-0.21 (-2.34%)

AG

First Majestic

$6.16

-0.05 (-0.81%)

KEY

KeyCorp

$18.66

-0.58 (-3.01%)

PENN

Penn National

$29.91

1.33 (4.65%)

CCS

Century Communities

$23.45

-0.09 (-0.38%)

FOE

Ferro

$18.60

-0.77 (-3.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 17

    Oct

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 13

    Nov

  • 16

    Nov

  • 04

    Dec

  • 11

    Jan

  • 16

    Feb

ONCS

OncoSec

$1.51

0.03 (2.03%)

, MRK

Merck

$69.77

1.41 (2.06%)

07:34
10/15/18
10/15
07:34
10/15/18
07:34
Hot Stocks
OncoSec initiates Phase 2 cllinical trial of Tavo with Merck's Keytruda »

OncoSec (ONCS) has…

ONCS

OncoSec

$1.51

0.03 (2.03%)

MRK

Merck

$69.77

1.41 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

LLY

Eli Lilly

$110.49

2.54 (2.35%)

06:50
10/15/18
10/15
06:50
10/15/18
06:50
Hot Stocks
Eli Lilly to present COAST-V, COAST-W data at ACR/ARHP »

Eli Lilly announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 06

    Nov

  • 07

    Nov

DVAX

Dynavax

$11.28

0.12 (1.08%)

, MRK

Merck

$69.77

1.41 (2.06%)

06:11
10/15/18
10/15
06:11
10/15/18
06:11
Hot Stocks
Dynavax's SD-101 combined with Merck's Keytruda selected in breast cancer trial »

Dynavax (DVAX) and…

DVAX

Dynavax

$11.28

0.12 (1.08%)

MRK

Merck

$69.77

1.41 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

RHHBY

Roche

$0.00

(0.00%)

05:41
10/15/18
10/15
05:41
10/15/18
05:41
Hot Stocks
Roche announces launch of 3 new NGS AVENIO Tumor Tissue Analysis Kits »

Roche announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

  • 07

    Nov

  • 24

    Dec

RHHBY

Roche

$0.00

(0.00%)

05:37
10/15/18
10/15
05:37
10/15/18
05:37
Hot Stocks
Genentech says Phase III KATHERINE study met primary endpoint »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

  • 07

    Nov

  • 24

    Dec

Saturday
AZN

AstraZeneca

$37.15

-0.49 (-1.30%)

, BMY

Bristol-Myers

$57.50

(0.00%)

07:04
10/13/18
10/13
07:04
10/13/18
07:04
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AZN

AstraZeneca

$37.15

-0.49 (-1.30%)

BMY

Bristol-Myers

$57.50

(0.00%)

LLY

Eli Lilly

$110.49

2.54 (2.35%)

GSK

GlaxoSmithKline

$38.31

-0.17 (-0.44%)

JNJ

Johnson & Johnson

$133.78

-0.03 (-0.02%)

MRK

Merck

$69.77

1.41 (2.06%)

NVS

Novartis

$82.77

0.56 (0.68%)

PFE

Pfizer

$43.78

0.97 (2.27%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$42.89

-0.83 (-1.90%)

NYT

New York Times

$24.98

0.145 (0.58%)

STMP

Stamps.com

$214.32

-0.43 (-0.20%)

AMZN

Amazon.com

$1,788.63

69.51 (4.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 24

    Dec

  • 11

    Jan

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

  • 28

    Apr

Friday
MRK

Merck

$69.24

0.88 (1.29%)

12:50
10/12/18
10/12
12:50
10/12/18
12:50
Options
Merck calls lead puts 10:1 »

Merck calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

AZN

AstraZeneca

$37.39

-0.25 (-0.66%)

10:03
10/12/18
10/12
10:03
10/12/18
10:03
Hot Stocks
AstraZeneca's olaparib granted orphan status as pancreatic cancer treatment »

AstraZeneca's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.